Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.78 USD | -0.21% | +3.11% | +52.23% |
May. 13 | Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating | MT |
May. 10 | Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 49
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bronson Crouch
CEO | Chief Executive Officer | 51 | 18-10-31 |
Sandeep Laumas
DFI | Director of Finance/CFO | 56 | 20-05-31 |
Mark Dudley
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-30 |
Robert Hawkins
CTO | Chief Tech/Sci/R&D Officer | 69 | 22-11-10 |
John Moore
PRN | Corporate Officer/Principal | 59 | 20-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Neil Gibson
BRD | Director/Board Member | 67 | 20-05-31 |
Richard McGaughy
BRD | Director/Board Member | 52 | 20-05-31 |
Director/Board Member | 49 | 20-06-30 | |
Bronson Crouch
CEO | Chief Executive Officer | 51 | 18-10-31 |
George Matcham
BRD | Director/Board Member | 72 | 18-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,503,913 | 6,058,922 ( 93.16 %) | 0 | 93.16 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.23% | 76.75M | |
+28.31% | 48.16B | |
-0.24% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.98% | 25.59B | |
-22.69% | 18.96B | |
+8.59% | 12.92B | |
+29.89% | 12.03B | |
-1.73% | 11.77B |
- Stock Market
- Equities
- TIL Stock
- Company Instil Bio, Inc.